CANC — Tema Oncology ETF
Data updated: 2026-07-29
CANC — Tema Oncology ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $176.14M AUM · 0.75% expense ratio · 60.0% 1-yr return. From SEC regulatory filings.
CANC Fund Overview
CANC — Tema Oncology ETF is a US ETF managed by Tema ETF Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Tema ETF Trust
- Category: United States Health Care Equity
- Assets under management: $176.14M
- 1-year return: 60.0%
- Ticker: CANC
- SEC CIK: 0001944285
- SEC series ID: S000078299
- Share class ID: C000239059
CANC Holdings
Top 10 holdings of Tema Oncology ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Revolution Medicines Inc | 7.73% |
| Eli Lilly & Co | 4.82% |
| Roche Holding AG | 4.21% |
| Cogent Biosciences Inc | 4.10% |
| Novartis AG | 4.03% |
| Immunome Inc | 3.91% |
| Celcuity Inc | 3.58% |
| Merck & Co Inc | 3.57% |
| AstraZeneca PLC | 3.54% |
| Nuvalent Inc | 3.37% |
CANC Portfolio Allocation
Asset-class allocation of Tema Oncology ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.0% |
| Cash & Equivalents | 1.1% |
CANC Performance
Total returns for CANC (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 9.8% |
| 1 year | 60.0% |
| 3 years (annualised) | 17.2% |
CANC Risk Information
Risk metrics for CANC, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.2%
CANC Costs and Fees
CANC costs about $75 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.75%
- Gross expense ratio: 0.99%
- Portfolio turnover: 68%
- Brokerage commissions: 4.22 bps of average net assets (SEC N-CEN)
CANC Cashflows
Over the 12 months to 2026-02, Tema Oncology ETF had net inflows of $54.87M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-02 | $9.03M |
| 2026-01 | $23.51M |
| 2025-12 | $13.57M |
| 2025-11 | $4.46M |
| 2025-10 | $615.41K |
| 2025-09 | $3.76M |
CANC Debt Constituents
No individual debt constituents are reported in Tema Oncology ETF's latest SEC N-PORT filing.
CANC Prospectus and SEC Filings
Official Tema Oncology ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.